Delivery Order SPE2DR25D3103-SPE2DR26F9J87
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Lenvima 8 mg daily dose tablets (60-count) with a ceiling value of $10,223.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by November 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count package. This firm fixed-price delivery order, valued at $10,223.24, is scheduled for completion by August 12, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was not designated as a set-aside contract and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lenvima 14 mg daily dose tablets (60-count units) with a contract ceiling value of $10,223.24. This firm fixed price delivery order, which is expected to be completed by September 9, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lenvima 14 mg daily dose (60-count units) with a contract value of $10,223.24 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of December 1, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units. The order is a firm fixed price delivery order with an ultimate completion date of November 18, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lenvima 8 mg daily dose tablets (60-unit supply) on October 27, 2025, with completion targeted for November 18, 2025. This award represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lenvima 8 mg daily dose in quantities of 60 units, with a ceiling value of $10,773.72 and completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement. The award...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of LENVIMA 14 mg daily dose tablets (60-count packaging) with a contract ceiling value of $10,223.24. This competitive award, issued under a firm fixed price delivery order with no set-aside designation, is scheduled for ultimate completion on September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J87Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lenvima 8 mg daily dose tablets in a quantity of 60 units, valued at $10,773.72. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and was competitively awarded without set-aside provisions. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate operations. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. Lenvima is a specialty oncology medication, consistent with AmerisourceBergen's portfolio of brand-name and generic drugs, vaccines, and specialized medical commodities that serve the Defense Health Agency and other government healthcare systems through this flexible global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 11/25/25 |